In this webinar, experts from the UK Cancer Genetics Group (UKCGG) discuss how care for individuals and families with RUNX1 familial platelet disorder (RUNX1-FPD) is delivered within the UK’s National Health Service (NHS).

Panelists explain current care pathways, genetic testing and result interpretation, hematology monitoring, and family planning options, including IVF and preimplantation genetic testing (PGT-M).

This session offers practical guidance for RUNX1-FPD patients and families, highlighting how national collaboration across genetics, hematology, and research is helping improve patient care and coordination in the UK.